Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Disease Progression × Clear all

Phase

Phase NA 5 Phase 2 5 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Recruiting 3 Completed 3 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 120 Carcinoma, Non-Small-Cell Lung 86 Colorectal Neoplasms 79 Carcinoma, Hepatocellular 63 Stomach Neoplasms 59 Rectal Neoplasms 46 Neoplasms 44 Nasopharyngeal Carcinoma 37 Lung Neoplasms 37 Lymphoma, Large B-Cell, Diffuse 36 Leukemia, Myeloid, Acute 36 Colonic Neoplasms 36 Neoplasm Metastasis 33 Prostatic Neoplasms 31 Multiple Myeloma 29 Lymphoma, Follicular 29 Esophageal Neoplasms 29 Uterine Cervical Neoplasms 27 Ovarian Neoplasms 27 Lymphoma 26 Leukemia 26 Pancreatic Neoplasms 25 Recurrence 20 Lymphoma, Non-Hodgkin 18 Urinary Bladder Neoplasms 17 Head and Neck Neoplasms 17 Brain Neoplasms 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Lymphoma, Mantle-Cell 15

Interventions

Temozolomide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02761070 2023-03-08

RE-GEND

Kyorin University

Phase 3 Unknown

Glioblastoma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡